サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421807

関節痛注射市場、シェア、規模、動向、産業分析レポート：製品別、関節タイプ別、流通チャネル別、地域別、セグメント別予測、2023年～2032年

Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product ; By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
関節痛注射市場、シェア、規模、動向、産業分析レポート：製品別、関節タイプ別、流通チャネル別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年12月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の関節痛注射市場規模は2032年までに123億6,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

関節痛注射の適応拡大には大きなチャンスがあります。現在、これらの注射は変形性関節症や関連疾患に使用されています。しかし、研究開発の努力により、腱炎、滑液包炎、その他の筋骨格系疾患など、より幅広い関節疾患をカバーできる可能性のある新たな適応症が模索されています。

多血小板血漿（PRP）、幹細胞治療、ヒアルロン酸誘導体を含む生物学的関節痛注射の開発と使用は、注目すべき成長機会を提示しています。生物学的製剤の注射には再生可能性があり、組織の修復と治癒を促すことができます。関節痛の注射市場に生物製剤を取り入れることで、特に関節疾患の再生ソリューションを求める患者にとって、先進的かつホリスティックな治療オプションが導入されます。

個別化医療は、様々なヘルスケア分野で注目を集めています。特定の関節の状態、病歴、遺伝的要因に基づいて個々の患者に合わせた関節痛注射を行うことで、治療成績が大幅に向上します。薬剤の選択、投与量、治療計画をカスタマイズすることで、ヘルスケアプロバイダーは関節痛注射の効果を最適化し、患者に合わせた高度な疼痛管理ソリューションを提供することができます。

COVID後の時代には、遠隔医療やバーチャルヘルスケア診察の採用が広まっています。患者は関節痛の問題を遠隔で相談することにますます前向きになっており、ヘルスケアプロバイダーは関節痛の評価、診断、注射の処方に遠隔医療を活用しています。この統合は利便性を提供し、対面診療の必要性を減らすもので、パンデミックによる患者の嗜好の変化と一致しています。

患者体験は重要性を増しています。ヘルスケアプロバイダーは、信頼と満足を醸成する患者中心の環境づくりに注力しています。このアプローチには、強化されたコミュニケーション、個別化されたケアプラン、関節痛の注射を希望する患者に対する包括的なサポートなどが含まれます。

関節痛注射市場レポート・ハイライト

ヒアルロン酸注射は、痛みの緩和と関節の改善のための非外科的選択肢に対する需要の高まりにより、最大セグメントとして浮上しました。

膝関連疾患の罹患率の高さ、侵襲性の低い治療への嗜好、患者の意識の高まりから、膝が最大セグメントとして浮上

主に消費者の需要の高まり、利便性、アクセスのしやすさ、eコマースとの統合によるものです。

北米地域は、人口の高齢化、変形性関節症のような関節関連疾患の有病率の上昇、非外科的治療オプションに対する需要の高まりにより、2022年の市場シェアの過半数を占めました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の関節痛注射市場の洞察

  • 関節痛注射市場- 関節タイプのスナップショット
  • 関節痛注射市場力学
    • 促進要因と機会
      • 人口の高齢化、関節疾患の蔓延、低侵襲治療の需要の増加
      • バイオテクノロジーと革新的な製剤の進歩
    • 抑制要因と課題
      • 厳格な規制当局の承認とコンプライアンスの課題
  • PESTEL分析
  • 関節痛注射市場の関節タイプの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の関節痛注射市場、製品別

  • 主な調査結果
  • イントロダクション
  • コルチコステロイド注射
  • ヒアルロン酸注射
  • 多血小板血漿注射
  • 幹細胞注射
  • その他

第6章 世界の関節痛注射市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 小売薬局
  • 病院薬局
  • オンライン薬局

第7章 世界の関節痛注射市場、関節タイプ別

  • 主な調査結果
  • イントロダクション
  • ヒップ
  • 膝
  • 肩と肘
  • 手と手首
  • その他

第8章 世界の関節痛注射市場、地域別

  • 主な調査結果
  • イントロダクション
    • 関節痛注射市場評価、地域別、2019-2032年
  • 関節痛注射市場-北米
    • 北米：関節痛注射市場、製品別、2019-2032年
    • 北米：関節痛注射市場、関節タイプ別、2019-2032年
    • 北米：関節痛注射市場、流通チャネル別、2019-2032年
    • 関節痛注射市場-米国
    • 関節痛注射市場- カナダ
  • 関節痛注射市場- 欧州
    • 欧州：関節痛注射市場、製品別、2019-2032年
    • 欧州：関節痛注射市場、関節タイプ別、2019～2032年
    • 欧州：関節痛注射市場、流通チャネル別、2019～2032年
    • 関節痛注射市場- 英国
    • 関節痛注射市場- フランス
    • 関節痛注射市場- ドイツ
    • 関節痛注射市場- イタリア
    • 関節痛注射市場- スペイン
    • 関節痛注射市場- オランダ
    • 関節痛注射市場- ロシア
  • 関節痛注射市場- アジア太平洋
    • アジア太平洋：関節痛注射市場、製品別、2019～2032年
    • アジア太平洋：関節痛注射市場、関節タイプ別、2019～2032年
    • アジア太平洋：関節痛注射市場、流通チャネル別、2019～2032年
    • 関節痛注射市場- 中国
    • 関節痛注射市場- インド
    • 関節痛注射市場- マレーシア
    • 関節痛注射市場- 日本
    • 関節痛注射市場- インドネシア
    • 関節痛注射市場- 韓国
  • 関節痛注射市場-中東およびアフリカ
    • 中東およびアフリカ：関節痛注射市場、製品別、2019～2032年
    • 中東およびアフリカ：関節痛注射市場、関節タイプ別、2019～2032年
    • 中東およびアフリカ：関節痛注射市場、流通チャネル別、2019-2032年
    • 関節痛注射市場- サウジアラビア
    • 関節痛注射市場- アラブ首長国連邦
    • 関節痛注射市場- イスラエル
    • 関節痛注射市場- 南アフリカ
  • 関節痛注射市場-ラテンアメリカ
    • ラテンアメリカ：関節痛注射市場、製品別、2019-2032年
    • ラテンアメリカ：関節痛注射市場、関節タイプ別、2019-2032年
    • ラテンアメリカ：関節痛注射市場、流通チャネル別、2019-2032年
    • 関節痛注射市場- メキシコ
    • 関節痛注射市場- ブラジル
    • 関節痛注射市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AbbVie Inc
  • Alkem Laboratories
  • Anika Therapeutics
  • Bioventus
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • GlaxoSmithKline（GSK）
  • Johnson & Johnson
  • Merck
  • Pacira BioSciences, Inc.
  • Pfizer
  • Sanofi
  • Seikagaku Corporation
  • Teva Pharmaceuticals
  • Zimmer Biomet
図表

List of Tables

  • Table 1 Global Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 3 Global Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 4 Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 11 Canada: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Canada: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 14 Europe: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Europe: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 17 UK: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 UK: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 20 France: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 France: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Germany: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 26 Italy: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Italy: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 29 Spain: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Spain: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 35 Russia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Russia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 41 China: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 44 India: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 50 Japan: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 65 UAE: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 UAE: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 68 Israel: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Israel: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 South Africa: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Latin America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Mexico: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Argentina: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Joint Pain Injections Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Joint Pain Injections Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Joint Pain Injections Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Joint Type
  • Figure 11. Global Joint Pain Injections Market, by Joint Type, 2022 & 2032 (USD Billion)
  • Figure 12. Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Joint Pain Injections Market
目次
Product Code: PM4129

The global joint pain injections market size is expected to reach USD 12.36 billion by 2032, according to a new study by Polaris Market Research. The report "Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, Stem Cell Injections, Others); By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

There is a significant opportunity to expand the indications for joint pain injections. Currently, these injections are used for osteoarthritis and related conditions. However, research and development efforts are exploring new indications, potentially covering a broader range of joint conditions, such as tendinitis, bursitis, and other musculoskeletal disorders.

The development and use of biologic joint pain injections, including platelet-rich plasma (PRP), stem cell therapies, and hyaluronic acid derivatives, present a notable growth opportunity. Biologic injections have regenerative potential and can stimulate tissue repair and healing. Incorporating biologics into the joint pain injection market introduces advanced and holistic treatment options, particularly for patients seeking regenerative solutions for their joint conditions.

Personalized medicine is gaining prominence across various healthcare sectors. Tailoring joint pain injections to individual patients based on their specific joint condition, medical history, and genetic factors significantly enhances treatment outcomes. By customizing the choice of medication, dosage, and treatment plan, healthcare providers optimize the effectiveness of joint pain injections and deliver highly tailored pain management solutions to patients.

The adoption of telemedicine and virtual healthcare consultations has become more widespread in the post-COVID era. Patients are increasingly open to discussing joint pain issues remotely, and healthcare providers are leveraging telemedicine to evaluate, diagnose, and prescribe joint pain injections. This integration offers convenience and reduces the need for in-person visits, which aligns with pandemic-induced changes in patient preferences.

The patient experience has gained significance. Healthcare providers are focusing on creating a patient-centered environment that fosters trust and satisfaction. This approach includes enhanced communication, personalized care plans, and comprehensive support for individuals seeking joint pain injections.

Joint Pain Injections Market Report Highlights

Hyaluronic acid injections emerged as the largest segment on account of greater demand for non-surgical alternatives for pain relief and joint improvement

Knee emerged as the largest segment on account of higher incidence of knee-related conditions, preference towards less invasive treatments, and increased patient awareness

Retail pharmacies held the maximum market revenue share in 2022, mainly due to growing consumer demand, convenience, easy access, and e-commerce integration

North America region dominated the market with a majority share in 2022, owing to an aging population, rising prevalence of joint-related conditions like osteoarthritis, and growing demand for non-surgical treatment options

The global key market players include: Anika Therapeutics, Bioventus, Eli Lilly and Company, Ferring Pharmaceuticals, and Pacira BioSciences, Inc., among others

Polaris Market Research has segmented the Joint Pain Injections market report based on product, joint type, distribution channel, and region:

Joint Pain Injections, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Platelet-Rich Plasma Injections
  • Stem Cell Injections
  • Others

Joint Pain Injections, Joint Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hip
  • Knee
  • Shoulder and Elbow
  • Hand and Wrist
  • Others

Joint Pain Injections, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Joint Pain Injections, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Joint Pain Injections Market Insights

  • 4.1. Joint Pain Injections Market - Joint Type Snapshot
  • 4.2. Joint Pain Injections Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Aging population, prevalence of joint disorders, and rise in demand for minimally invasive treatments
      • 4.2.1.2. Advancements in biotechnology and innovative formulations
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulatory approvals and compliance challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Joint Pain Injections Market Joint Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Joint Pain Injections Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Corticosteroid Injections
    • 5.3.1. Global Joint Pain Injections Market, by Corticosteroid Injections, by Region, 2019-2032 (USD Billion)
  • 5.4. Hyaluronic Acid Injections
    • 5.4.1. Global Joint Pain Injections Market, by Hyaluronic Acid Injections, by Region, 2019-2032 (USD Billion)
  • 5.5. Platelet-Rich Plasma Injections
    • 5.5.1. Global Joint Pain Injections Market, by Platelet-Rich Plasma Injections, by Region, 2019-2032 (USD Billion)
  • 5.6. Stem Cell Injections
    • 5.6.1. Global Joint Pain Injections Market, by Stem Cell Injections, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Joint Pain Injections Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Joint Pain Injections Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Retail Pharmacies
    • 6.3.1. Global Joint Pain Injections Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Global Joint Pain Injections Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.5. Online Pharmacies
    • 6.5.1. Global Joint Pain Injections Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

7. Global Joint Pain Injections Market, by Joint Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • 7.3. Hip
    • 7.3.1. Global Joint Pain Injections Market, by Hip, By Region, 2019-2032 (USD Billion)
  • 7.4. Knee
    • 7.4.1. Global Joint Pain Injections Market, by Knee, By Region, 2019-2032 (USD Billion)
  • 7.5. Shoulder and Elbow
    • 7.5.1. Global Joint Pain Injections Market, by Shoulder and Elbow, By Region, 2019-2032 (USD Billion)
  • 7.6. Hand and Wrist
    • 7.6.1. Global Joint Pain Injections Market, by Hand and Wrist, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Joint Pain Injections Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Joint Pain Injections Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Joint Pain Injections Market - North America
    • 8.3.1. North America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Joint Pain Injections Market - U.S.
      • 8.3.4.1. U.S.: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Joint Pain Injections Market - Canada
      • 8.3.5.1. Canada: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Joint Pain Injections Market - Europe
    • 8.4.1. Europe: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Joint Pain Injections Market - UK
      • 8.4.4.1. UK: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Joint Pain Injections Market - France
      • 8.4.5.1. France: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Joint Pain Injections Market - Germany
      • 8.4.6.1. Germany: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Joint Pain Injections Market - Italy
      • 8.4.7.1. Italy: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Joint Pain Injections Market - Spain
      • 8.4.8.1. Spain: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Joint Pain Injections Market - Netherlands
      • 8.4.9.1. Netherlands: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Joint Pain Injections Market - Russia
      • 8.4.10.1. Russia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Joint Pain Injections Market - Asia Pacific
    • 8.5.1. Asia Pacific: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Joint Pain Injections Market - China
      • 8.5.4.1. China: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Joint Pain Injections Market - India
      • 8.5.5.1. India: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Joint Pain Injections Market - Malaysia
      • 8.5.6.1. Malaysia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Joint Pain Injections Market - Japan
      • 8.5.7.1. Japan: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Joint Pain Injections Market - Indonesia
      • 8.5.8.1. Indonesia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Joint Pain Injections Market - South Korea
      • 8.5.9.1. South Korea: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Joint Pain Injections Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Joint Pain Injections Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Joint Pain Injections Market - UAE
      • 8.6.5.1. UAE: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Joint Pain Injections Market - Israel
      • 8.6.6.1. Israel: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Joint Pain Injections Market - South Africa
      • 8.6.7.1. South Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Joint Pain Injections Market - Latin America
    • 8.7.1. Latin America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Joint Pain Injections Market - Mexico
      • 8.7.4.1. Mexico: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Joint Pain Injections Market - Brazil
      • 8.7.5.1. Brazil: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Joint Pain Injections Market - Argentina
      • 8.7.6.1. Argentina: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Alkem Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Anika Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bioventus
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eli Lilly and Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Ferring Pharmaceuticals
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. GlaxoSmithKline (GSK)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pacira BioSciences, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sanofi
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Seikagaku Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceuticals
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zimmer Biomet
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development